MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$12,123K
Free Cash flow
-$27,459K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of investments
Equity-based compensation
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Medical expenses payable
Prepaid expenses and other curre...
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
36,560
11,416
-11,006
3,729
Provision for credit loss
265
-
285
286
(gain) loss on right of use assets
-
-
0
0
Gain on sale of property and equipment
1
-
0
0
Depreciation and amortization
7,857
7,862
7,834
7,985
Amortization-investment discount
105
245
257
310
Amortization-debt issuance costs
640
507
440
440
Equity-based compensation
18,174
14,019
13,115
16,227
Non-cash lease expense
479
450
431
932
Loss on extinguishment of debt
-
-
0
-
Accounts receivable
19,480
24,471
33,655
-62,808
Prepaid expenses and other current assets
20,449
47,256
-27,267
27,993
Other assets
-27
16
3
-5
Medical expenses payable
-43,219
181,398
-54,227
73,642
Accounts payable and accrued expenses
-1,611
287
-816
2,626
Deferred premium revenue
-
-
-
-72
Accrued compensation
4,101
-14,725
733
5,264
Lease liabilities
-552
-544
-511
-1,013
Net cash provided by operating activities
-17,314
128,682
-50,375
144,556
Purchase of investments
6,237
10,598
20,439
10,193
Sale of property and equipment
0
-
0
0
Maturities of investments
18,800
18,540
18,305
18,005
Sale of business
0
-
0
0
Acquisition of property and equipment
10,145
7,364
5,029
5,497
Net cash provided by (used in) investing activities
2,418
578
-7,163
2,315
Proceeds from long-term debt
-
-
0
0
Repayment of long-term debt
-
-
0
-
Payment of employment taxes related to release of restricted stock
-
-
0
0
Debt issuance costs
739
1,658
0
0
Proceeds from stock option exercises
3,512
2,173
15,296
948
Contributions from noncontrolling interest holders
-
-
0
0
Net cash provided by financing activities
2,773
515
15,296
948
Net increase in cash
-12,123
129,775
-42,242
147,819
Cash, cash equivalents and restricted cash at beginning of period
707,712
577,937
620,178
434,942
Cash, cash equivalents and restricted cash at end of period
695,589
707,712
577,937
620,178
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from stock
option exercises
$3,512K
(117.33%↑ Y/Y)
Maturities of investments
$18,800K
(8.70%↑ Y/Y)
Net cash provided by
financing activities
$2,773K
(71.60%↑ Y/Y)
Net cash provided by
(used in) investing...
$2,418K
(136.28%↑ Y/Y)
Canceled cashflow
$739K
Canceled cashflow
$16,382K
Net increase in cash
-$12,123K
(-150.34%↓ Y/Y)
Canceled cashflow
$5,191K
Net income
$36,560K
(133.57%↑ Y/Y)
Equity-based compensation
$18,174K
(16.85%↑ Y/Y)
Depreciation and
amortization
$7,857K
(11.67%↑ Y/Y)
Accrued compensation
$4,101K
(-61.54%↓ Y/Y)
Amortization-debt issuance costs
$640K
(45.12%↑ Y/Y)
Non-cash lease expense
$479K
(421.48%↑ Y/Y)
Provision for credit loss
$265K
(1.15%↑ Y/Y)
Other assets
-$27K
(-193.10%↓ Y/Y)
Debt issuance costs
$739K
Acquisition of property and
equipment
$10,145K
(26.76%↑ Y/Y)
Purchase of investments
$6,237K
(-63.52%↓ Y/Y)
Net cash provided by
operating activities
-$17,314K
(-159.44%↓ Y/Y)
Canceled cashflow
$68,103K
Medical expenses
payable
-$43,219K
(-173.98%↓ Y/Y)
Prepaid expenses and
other current assets
$20,449K
(63.16%↑ Y/Y)
Accounts receivable
$19,480K
(-71.81%↓ Y/Y)
Accounts payable and
accrued expenses
-$1,611K
(-148.15%↓ Y/Y)
Lease liabilities
-$552K
(-749.41%↓ Y/Y)
Amortization-investment discount
$105K
(-70.91%↓ Y/Y)
Gain on sale of
property and equipment
$1K
(-98.61%↓ Y/Y)
Buy us a coffee
logo-alignment-vertical-svg
Alignment Healthcare, Inc. (ALHC)
logo-alignment-vertical-svg
Alignment Healthcare, Inc. (ALHC)